Class Suit Accuses Enzymotec Of Lying Before Its $70M IPO
Israeli biotechnology and health products company Enzymotec Ltd. was hit with a putative securities class action in New Jersey federal court Friday, alleging it defrauded investors by misrepresenting the company's potential...To view the full article, register now.
Already a subscriber? Click here to view full article